Investors’ thirst for Lemonade a good sign for other insurtechs

Lemonade’s soaring share price in its first day of trading will help assuage fears over how insurtechs are viewed in a post-Covid world.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com

      InsurTech and innovation
      Capital raising
      Lemonade